Gregory MacMichael

Gregory MacMichael

No open positions remaining
70 year
Health Technology
Consumer Services

Profile

Gregory MacMichael is the founder of CMC BioServices LLC, which was founded in 2010.
He held former positions as Vice President at Wyeth LLC, Global Head-Biologics Development at Novartis AG, Senior Vice President-Process Development at Rocket Pharmaceuticals, Inc., Senior Vice President-Development & Manufacturing at NantKwest, Inc. from 2017 to 2018, and Senior Vice President-Technical Operations at Sio Gene Therapies, Inc. from 2018 to 2019.
He was also the Chief Technology Officer at Castle Creek Biosciences, Inc. from 2020 to 2021 and Chief Technical Officer at Coya Therapeutics, Inc. He received a doctorate from Mississippi State University, a graduate and doctorate degree from North Carolina State University, and an undergraduate degree from The Pennsylvania State University.

Former positions of Gregory MacMichael

CompaniesPositionEnd
SIO GENE THERAPIES INC. Corporate Officer/Principal 01/07/2019
IMMUNITYBIO, INC. Corporate Officer/Principal 01/09/2018
ROCKET PHARMACEUTICALS, INC. Corporate Officer/Principal 01/12/2016
COYA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of Gregory MacMichael's experience

Training of Gregory MacMichael

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

7

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

CMC BioServices LLC

  1. Stock Market
  2. Insiders
  3. Gregory MacMichael
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!